This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

PCC 2024 — Pharmaceutical Compliance Congress

NETWORKING BEGINS IN

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
Delivered as a Hybrid Event
April 16-18, 2024The Ritz-Carlton, Tysons Corner | McLean, VA

Genevieve Spires
Deputy General Counsel at Melinta Therapeutics
Speaker

Profile

Genevieve Spires is Deputy General Counsel at Melinta Therapeutics, a commercial-stage pharmaceutical company specializing in providing innovative therapies to patients suffering from acute and life-threatening illnesses. She counsels a diverse group of business clients, serving as primary legal counsel to the commercial, medical affairs, and clinical teams and partnering closely with compliance to provide guidance on regulatory compliance, stakeholder interactions, product promotion, and other legal and compliance matters relating to the company’s marketed products and investigational agents. Previously, Genevieve was a shareholder in Buchanan, Ingersoll & Rooney’s FDA & Biotechnology section, where she counseled pharmaceutical and device companies on FDA regulatory compliance and fraud and abuse matters, with a focus on lawful product promotion.

Agenda Sessions

  • Compliance Blueprint for Product Launch Success

    3:15pm